SD suppresses multiplication of melanoma B16F10 cells, diminishes permeability for Ca2+ ions and decreases protein levels of COX-2, and increases degradation of phospholipases PLA2 and PLCγ1 and diminishes enzymatic activity of the Ca2+-dependent cPLA2. The gene discussed is PLCG1; the disease is melanoma.